Ana Paula de Souza

Prof. Dr. Ana Paula de Souza

Bioscience, University of Campinas-UNICAMP, Campinas, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Epigenomes
Verified
Journal Article
Open access
PDF file
Ana Paula de SouzaAna Paula de Souza
Ana Paula de Souza
VMVitor Marinho
Vitor Marinho
MMMarcelo Rocha Marques
Marcelo Rocha Marques
Epigenetic modifications act as crucial regulators of gene activity and are influenced by both internal and external environmental factors, with diet being the most impactful external factor. On the other hand, cellular metabolism encompasses a complex network of biochemical reactions essential for maintaining cellular function, and it impacts every cellular process. Many metabolic cofactors are critical for the activity of chromatin-modifying enzymes, influencing methylation and the global acetylation status of the epigenome. For instance, dietary nutrients, particularly those involved in one-carbon metabolism (e.g., folate, vitamins B12 and B6, riboflavin, methionine, choline, and betaine), take part in the generation of S-adenosylmethionine (SAM), which represents the main methyl donor for DNA and histone methylation; α-ketoglutarate and ascorbic acid (vitamin C) act, respectively, as a co-substrate and cofactor for Ten-eleven Translocation (TET), which is responsible for DNA demethylation; and metabolites such as Acetyl-CoA directly impact histone acetylation, linking metabolism of the TCA cycle to epigenetic regulation. Further, bioactive compounds, such as polyphenols, modulate epigenetic patterns by affecting methylation processes or targeting epigenetic enzymes. Since diet and nutrition play a critical role in shaping epigenome functions and supporting human health, this review offers a comprehensive update on recent advancements in metabolism, epigenetics, and nutrition, providing insights into how nutrients contribute to metabolic balance, epigenome integrity maintenance and, consequently, disease prevention.

16 July 2002 in European Journal of Immunogenetics
Verified
Journal Article
Closed access
PDF file
RCRaquel M. Scarel Caminaga
Raquel M. Scarel Caminaga
PTPaula Cristina Trevilatto
Paula Cristina Trevilatto
Ana Paula de SouzaAna Paula de Souza
Ana Paula de Souza
RBR. B. Brito
R. B. Brito
SLSergio Roberto Peres Line
Sergio Roberto Peres Line

1 January 2022
Verified
Journal Article
Closed access
Dieila Giomo de LimaDieila Giomo de Lima
Dieila Giomo de Lima
GAGuilherme Castro Lima Silva Do Amaral
Guilherme Castro Lima Silva Do Amaral
APAline Cristiane Planello
Aline Cristiane Planello
GBGabriell Bonifacio Borgato
Gabriell Bonifacio Borgato
GGGustavo Narvaes Guimarães
Gustavo Narvaes Guimarães
Ana Paula de SouzaAna Paula de Souza
Ana Paula de Souza

1 May 2019 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
GAGuilherme C.L.S. Do Amaral
Guilherme C.L.S. Do Amaral
APAline C. Planello
Aline C. Planello
GBGabriell Borgato
Gabriell Borgato
Dieila Giomo de LimaDieila Giomo de Lima
Dieila Giomo de Lima
GGGustavo N. Guimarães
Gustavo N. Guimarães
Ana Paula de SouzaAna Paula de Souza
Ana Paula de Souza

1 August 2020 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
GBGabriell Bonifacio Borgato
Gabriell Bonifacio Borgato
GBGabriel Alvares Borges
Gabriel Alvares Borges
Ana Paula de SouzaAna Paula de Souza
Ana Paula de Souza
CSCristiane H Squarize
Cristiane H Squarize
RCRogerio Castilho
Rogerio Castilho

Verified
Journal Article
Open access
PDF file
Dieila Giomo de LimaDieila Giomo de Lima
Dieila Giomo de Lima
GBGabriell Bonifácio Borgato
Gabriell Bonifácio Borgato
FSFelipe Luz Torres Silva
Felipe Luz Torres Silva
AVAndré Schwambach Vieira
André Schwambach Vieira
AFAlessandro Santos Farias
Alessandro Santos Farias
Ana Paula de SouzaAna Paula de Souza
Ana Paula de Souza
Therapy resistance remains a major cause of cancer-related mortality. Cisplatin (cis-diamminedichloroplatinum, CDDP) is a first-line chemotherapeutic agent for oral cancer, but intrinsic and acquired resistance substantially limit its clinical efficacy. Epithelial–mesenchymal transition (EMT) has been associated with drug resistance across multiple tumor types; however, its involvement in cisplatin resistance in oral cancer remains incompletely understood. Here, we established an in vitro model of cisplatin resistance using the squamous cell carcinoma 9 (SCC-9) cell line and generated two populations with distinct resistance levels. We observed morphological and transcriptional changes consistent with EMT-related features, including increased mRNA expression of Vimentin, SNAIL1, ZEB1, ZEB2, and CDH2. Resistant cells also exhibited reduced proliferation, whereas the intermediately resistant population, cisplatin-resistant 4 (CPR4), showed greater wound closure, suggesting enhanced migratory behavior and features consistent with a hybrid-like EMT state. Conversely, the more resistant subline, cisplatin-resistant 8 (CPR8), exhibited a more stationary phenotype. Transcriptomic profiling by RNA sequencing (RNA-seq) revealed extensive differential gene expression associated with EMT and cisplatin resistance. Functional enrichment analyses identified Gene Ontology (GO) terms related to cell adhesion, extracellular matrix organization, and calcium ion binding, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed enrichment of PI3K/Akt signaling. Together, our findings support a dynamic model in which distinct EMT-related transcriptional states are associated with different levels of cisplatin resistance. This study provides insights into transcriptional changes associated with resistance acquisition and highlights candidate genes and pathways for further investigation and functional validation in oral cancer.